Status:
COMPLETED
Surgical Intervention and Lymphatic Diseases.
Lead Sponsor:
Chang Gung Memorial Hospital
Conditions:
Lymphedema
Eligibility:
All Genders
20-90 years
Brief Summary
Supermicrosurgical LVA has been proven effective in treating moderate to severe lymphedema, including cases with diffuse dermal backflow (DB) and even severe lymphatic fluid leakage. Therefore, the us...
Detailed Description
Lymphatic-related diseases such as lymphedema often result from damage to the lymphatic system due to tumor removal and lymph node dissection surgeries, as well as tissue fibrosis caused by post-opera...
Eligibility Criteria
Inclusion
- This study including patients diagnosed with lymphatic-related diseases at Kaohsiung Chang Gung Memorial Hospital from September 1, 2015, to August 31, 2022.
Exclusion
- Patients under the age of 20.
- Patients with incomplete medical records.
Key Trial Info
Start Date :
September 23 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2023
Estimated Enrollment :
83 Patients enrolled
Trial Details
Trial ID
NCT06067880
Start Date
September 23 2022
End Date
September 1 2023
Last Update
October 5 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kaohsiung Chang Gung Memorial Hospital
Kaohsiung City, Taiwan, 83301